Robert Shenkar

Author PubWeight™ 19.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 2010 2.23
2 Genomics of human intracranial aneurysm wall. Stroke 2009 2.06
3 Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke 2011 1.91
4 Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion. Stroke 2005 1.70
5 A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet 2010 1.39
6 Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery 2004 1.29
7 Cerebral cavernous malformations: somatic mutations in vascular endothelial cells. Neurosurgery 2009 1.10
8 Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation. J Neurosurg 2007 1.01
9 Immune response in human cerebral cavernous malformations. Stroke 2009 0.94
10 Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol 2014 0.91
11 Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke 2013 0.91
12 Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus 2010 0.91
13 Cerebral cavernous malformations: clinical insights from genetic studies. Neurosurg Focus 2006 0.86
14 On-pump coronary artery bypass surgery activates human myocardial NF-kappaB and increases TNF-alpha in the heart. J Surg Res 2003 0.81
15 Corrigendum: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling. Nature 2016 0.79
16 Lipopolysaccharide-induced neutrophil gene expression under in vivo or in vitro conditions. Chest 2002 0.78